Researchers at Australian institutions have identified a distinct subtype of depression associated with disruptions to the body’s circadian rhythms, termed “circadian depression.” The findings were published in the British Journal of Psychiatry and analyzed clinical and genetic data from 11,380 Australians, predominantly those with severe and recurrent depression.
The research determined that approximately 23% of study participants met criteria for circadian depression, defined by at least three of six characteristics: seasonal illness patterns, delayed sleep timing, sleeping longer during depressive episodes, being a night owl, waking with significant fatigue, and social jetlag—the misalignment between weekday and weekend sleep schedules. According to Dr. Emiliana Tonini of the University of Sydney’s Brain and Mind Centre, individuals with this subtype exhibited more severe mental health symptoms, including earlier depression onset, more frequent episodes, increased suicidality, and hypomanic and psychotic-like symptoms compared to those without circadian depression.
The study identified genetic and biological markers distinguishing circadian depression from other forms. Individuals with this subtype showed higher genetic risk for ADHD and mood disorders, alongside elevated metabolic and inflammatory markers, suggesting the condition reflects distinct underlying biology rather than simply depression accompanied by poor sleep. Additionally, SSRIs and SNRIs—typical first-line antidepressant medications—demonstrated reduced effectiveness and increased side effects for those with circadian depression.
Researchers propose that treatments targeting circadian rhythms, such as melatonin and light therapy, alongside behavioral interventions focusing on sleep-wake cycle regularity, daylight exposure, and meal timing consistency, may prove more effective for this population. The ability to clinically diagnose circadian depression could enable more tailored treatment approaches, particularly for young people seeking mental health support initially.
The researchers acknowledged limitations, noting that participants were limited to those of genetically inferred European ancestry, potentially restricting generalizability. Some independent experts praised the study’s methodology, particularly its use of polygenic risk scoring to link depression to specific genetic profiles, though others called for further examination in diverse populations before firm conclusions are drawn.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI